2024-516878-30-00
Completed
Phase 1
A clinical study of MK-6916 and placebo in healthy people (MK-6916-003)
Merck Sharp & Dohme LLC1 site in 1 country16 target enrollmentStarted: December 3, 2024Last updated:
Overview
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Merck Sharp & Dohme LLC
- Enrollment
- 16
- Locations
- 1
Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 64 years (18-64 Years)
- Sex
- Male
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Jonathan Kurz
Scientific
Merck Sharp & Dohme LLC
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Phase 1
A clinical study of MK-6916 in healthy people (MK-6916-006)2025-521487-36-00Merck Sharp & Dohme LLC40
Recruiting
Phase 1
A clinical study of MK-6050 in healthy people (MK-6050-001)2025-523861-58-00Merck Sharp & Dohme LLC32
Recruiting
Phase 2/3
A clinical study of MK-6194 for the treatment of Systemic Lupus Erythematosus (SLE) (MK-6194-006)2023-505520-61-00Merck Sharp & Dohme LLC69
Completed
Phase 1
A clinical study of MK-2828 in healthy people (MK-2828-001)2024-513377-51-00Merck Sharp & Dohme LLC16
Recruiting
Phase 1
A clinical study of MK-1289 in healthy adult men (MK-1289-001)2025-521395-63-00Merck Sharp & Dohme LLC28